SummitTX Capital’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
SCM
FIS
VCM
SummitTX Capital's REPL Position: Q1 2026 in Review
SummitTX Capital increased its Replimune Group (REPL) stake by 166% in Q1 2026, buying an estimated $1.38M and bringing the position to 288,889 shares worth $2.21M. The position accounts for 0.07% of the portfolio, ranked #291.
SummitTX Capital first reported a position in REPL in Q1 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.
- SummitTX Capital held 288,889 shares of Replimune Group worth $2.21M as of Q1 2026.
- SummitTX Capital bought 180,086 Replimune Group shares in Q1 2026, an estimated $1.38M.
- Replimune Group made up 0.07% of SummitTX Capital's portfolio in Q1 2026, its #291 holding.
- SummitTX Capital first reported a position in Replimune Group in Q1 2025 and has held it in 4 quarters since.
- 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.
Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.